Compliance with a pharmacological secondary fracture prevention policy
Abstract
The aim of this study was to monitor the compliance of a specific group of patients to the initiation of pharmacological fracture prevention therapies, in particular calcium and Vitamin D3 supplements. We used a cohort of 276 patients admitted to one hospital with an acute hip fracture. Therapy was started in hospital and compliance checked at out patient follow-up. Written and verbal advice was given to support therapy. The mean age was 80.8 years and 82% were female. One hundred and ninety-nine patients were alive at one year from injury. For these patients 22 (11.1%) were on therapy prior to fracturing their hip. Of the remainder, 111/177 (62.7%) stated they were taking therapy to reduce the risk of fractures. These results demonstrate that an aggressive policy of prescribing can result in good levels of compliance with therapy.
How strong is the evidence?
Evidence Hub reads this as a cohort study, done in people. Its evidence level is 3 of 5 (Moderate · trial / cohort / secondary analysis). Trials without a large randomized design, cohorts and secondary analyses give moderate evidence. Reported size: 276 participants or records.
Read the paper
Related studies
- Effectiveness of Bisphosphonates and Denosumab on Risk of Vertebral Fractures in Prostate Cancer Patients Under Androgen Deprivation Therapies: A Real-World Prospective Study
- Osteoporosis-related fractures after spinal cord injury: a retrospective study from Brazil
- Serum 25-hydroxyvitamin D, parathyroid hormone, and mortality in older men
- Lack of Association between Vitamin D Insufficiency and Cardiovascular or Fracture Risk: A UK Biobank Study
- Muscle strength and body composition are clinical indicators of osteoporosis
- Incidence of bone protection and associated fragility injuries in patients with proximal femur fractures
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.